Gilead Sciences

In a test for AI, a buzzy machine learning startup inks drug discovery deal with Gilead
In a test for AI, a buzzy machine learning startup inks drug discovery deal with Gilead
Stat
artificial intelligence
machine learning
drug discovery
Insitro
Gilead Sciences
Flag link:
Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs
Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs
TheStreet.com
NASH
Gilead Sciences
Novo Nordisk
clinical trials
Flag link:
Gilead shores up hope for NASH cocktail with a glimpse at positive proof-of-concept data
Gilead shores up hope for NASH cocktail with a glimpse at positive proof-of-concept data
Endpoints
Gilead Sciences
NASH
cilofexor
firsocostat
selonsertib
Flag link:
Gilead cuts cardiopulmonary sales reps
Gilead cuts cardiopulmonary sales reps
BioCentury
Gilead Sciences
layoffs
generics
Letairis
Ranexa
Flag link:
The top 15 pharma companies by 2018 revenue
The top 15 pharma companies by 2018 revenue
Fierce Pharma
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Flag link:
Big Pharma come together for better drug side effect detection
Big Pharma come together for better drug side effect detection
Pharma Times
side effects
adverse events
Pfizer
Roche
Takeda
Eli Lilly
Bristol-Myers Squibb
Gilead Sciences
Alexion
Celgene
International Working Group on Signal Detection and Management in Pharmacovigilance
pharmacovigilance
Flag link:
Where Will Gilead Sciences Be in 5 Years? -- The Motley Fool
Where Will Gilead Sciences Be in 5 Years? -- The Motley Fool
Motley Fool
Gilead Sciences
Flag link:
Gilead sees Descovy as successor to Truvada for HIV PrEP
Gilead sees Descovy as successor to Truvada for HIV PrEP
BioCentury
Gilead Sciences
Descovy
Truvada
HIV
PrEP
Flag link:
Gilead earns needed trial win as arthritis drug succeeds in 2 studies
Gilead earns needed trial win as arthritis drug succeeds in 2 studies
Biopharma Dive
Gilead Sciences
filgotinib
clinical trials
FDA
Flag link:
Precision BioSciences Exceeds Expectations with IPO
Precision BioSciences Exceeds Expectations with IPO
CP Wire
Precision Biosciences
IPOs
Gilead Sciences
Flag link:
Precision BioSciences Exceeds Expectations with IPO
Precision Biosciences
IPOs
Gilead Sciences
Flag link:
Louisiana has picked its 'Netflix' hepatitis C partner: Gilead's new generics unit
Louisiana has picked its 'Netflix' hepatitis C partner: Gilead's new generics unit
Fierce Pharma
Louisiana
Gilead Sciences
hepatitis C
Asegua Therapeutics
Netflix model
Flag link:
Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%
Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%
Motley Fool
Gilead Sciences
GS-6207
HIV
Flag link:
Gilead raises prices on top-selling HIV treatments
Gilead raises prices on top-selling HIV treatments
Biopharma Dive
Gilead Sciences
drug pricing
HIV
Flag link:
New shareholder challenge to Gilead: What are you doing with billions in tax savings?
New shareholder challenge to Gilead: What are you doing with billions in tax savings?
Bizjournals
Gilead Sciences
taxes
tax reform
Flag link:
Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?
Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?
Fierce Pharma
Gilead Sciences
Truvada
PrEP
Descovy
Flag link:
Gilead shares early clinical data on HIV capsid inhibitor
Gilead shares early clinical data on HIV capsid inhibitor
Fierce Biotech
Gilead Sciences
HIV
GS-6207
clinical trials
Flag link:
Louisiana's 'Netflix' deal for hepatitis C drugs wins bids from AbbVie, Gilead and Merck
Louisiana's 'Netflix' deal for hepatitis C drugs wins bids from AbbVie, Gilead and Merck
Fierce Pharma
hepatitis C
AbbVie
Gilead Sciences
Louisiana
Netflix model
Flag link:
2 Biotech Stocks With Major Incoming Catalysts
2 Biotech Stocks With Major Incoming Catalysts
Yahoo/Motley Fool
Axsome Therapeutics
AXS-05
depression
Galapagos
filgotinib
Gilead Sciences
rheumatoid arthritis
Flag link:
Gilead scores key HIV data as Descovy proves non-inferior to Truvada
Gilead scores key HIV data as Descovy proves non-inferior to Truvada
BioPharma Dive
Gilead Sciences
HIV
Descovy
Truvada
clinical trials
Flag link:

Pages